Relationship Between Phase Solubility Diagrams and Crystalline Structures During Dissolution of Cimetidine/Cyclodextrin Complex Crystals.

Cimetidine Cyclodextrin Dissolution study Phase-solubility diagrams Polymorph

Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
07 2020
Historique:
received: 13 11 2019
revised: 05 03 2020
accepted: 18 03 2020
pubmed: 5 4 2020
medline: 22 6 2021
entrez: 5 4 2020
Statut: ppublish

Résumé

Cyclodextrins (CDs) form complex crystals with drugs and improve physicochemical properties of drugs. However, only few reports have summarized relationships between crystal structures of drug/CD and dissolution behavior. In this study, we developed cimetidine (CIM)/CD complex crystals to achieve sustained drug release and investigated the relationship between the dissolution behavior of CIM/CD complexes and their crystal structures. CIM and 3 types of CDs (α-, β-, and γ-CD) formed a complex crystal when subjected to solvent mixing. The CIM/CD complexes had a highly reduced dissolution rate compared to that of the physical mixture of CIM and CD. β-CD improved the solubility of CIM, whereas γ-CD decreased its solubility. Based on the phase solubility diagram, CIM and α-, β-, and γ-CD indicated A-type positive (A

Identifiants

pubmed: 32246979
pii: S0022-3549(20)30188-X
doi: 10.1016/j.xphs.2020.03.029
pii:
doi:

Substances chimiques

Cyclodextrins 0
Pharmaceutical Preparations 0
Cimetidine 80061L1WGD

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2206-2212

Informations de copyright

Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Auteurs

Shota Shimizu (S)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.

Ayako Wada-Hirai (A)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.

Yingpeng Li (Y)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan; Research Institute for Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510 Japan.

Yohsuke Shimada (Y)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan; Research Institute for Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510 Japan.

Yuta Otsuka (Y)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan; Research Institute for Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510 Japan.

Satoru Goto (S)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan; Research Institute for Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510 Japan. Electronic address: s.510@rs.tus.ac.jp.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Inclusion Bodies Solubility Recombinant Proteins Detergents Protein Denaturation

Elucidating ATP's role as solubilizer of biomolecular aggregate.

Susmita Sarkar, Saurabh Gupta, Chiranjit Mahato et al.
1.00
Adenosine Triphosphate Protein Aggregates Solubility Humans Protein Conformation

Comparative assessment of physics-based in silico methods to calculate relative solubilities.

Adiran Garaizar Suarez, Andreas H Göller, Michael E Beck et al.
1.00
Solvents Solubility Quantum Theory Molecular Dynamics Simulation Thermodynamics

Classifications MeSH